01 2BGP Pharma ULC
02 2Solvay Pharma Inc.
01 22115170
02 22250395
01 2Eprosartan Mesylate
02 2Eprosartan mesylate
01 4Tablet
01 22012-08-12
02 22017-03-26
Patent Expiration Date : 2017-03-26
Date Granted : 2005-09-06
Brand Name : TEVETEN
Patent Number : 2250395
Filing Date : 1997-03-26
Strength per Unit : 400 mg
Dosage Form : Tablet
Human Or VET : Human
Route of Administration : Oral
Patent Expiration Date : 2017-03-26
Date Granted : 2005-09-06
Patent Expiration Date : 2017-03-26
Date Granted : 2005-09-06
Brand Name : TEVETEN
Patent Number : 2250395
Filing Date : 1997-03-26
Strength per Unit : 600 mg
Dosage Form : Tablet
Human Or VET : Human
Route of Administration : Oral
Patent Expiration Date : 2017-03-26
Date Granted : 2005-09-06
Patent Expiration Date : 2012-08-12
Date Granted : 2004-05-25
Brand Name : TEVETEN
Patent Number : 2115170
Filing Date : 1992-08-12
Strength per Unit : 400 mg
Dosage Form : Tablet
Human Or VET : Human
Route of Administration : Oral
Patent Expiration Date : 2012-08-12
Date Granted : 2004-05-25
Patent Expiration Date : 2012-08-12
Date Granted : 2004-05-25
Brand Name : TEVETEN
Patent Number : 2115170
Filing Date : 1992-08-12
Strength per Unit : 600 mg
Dosage Form : Tablet
Human Or VET : Human
Route of Administration : Oral
Patent Expiration Date : 2012-08-12
Date Granted : 2004-05-25
LOOKING FOR A SUPPLIER?
